Medical research

Experimental drug shows promise for schizophrenia

An experimental drug may ease a range of symptoms that strike people with schizophrenia, without the side effects of existing medications, an early clinical trial suggests.

Inflammatory disorders

Major cause of inflammatory bowel disease discovered

Researchers at the Francis Crick Institute, working with UCL and Imperial College London, have discovered a new biological pathway that is a principal driver of inflammatory bowel disease (IBD) and related conditions, and ...

Diseases, Conditions, Syndromes

WHO suspends hydroxychloroquine trial as COVID-19 treatment

The World Health Organization said Monday it had temporarily suspended clinical trials of hydroxychloriquine as a potential treatment for COVID-19 being carried out across a range of countries as a precautionary measure.

page 4 from 40